false2022-06-30Q20001792267--12-31Inter-company receivables/payables represent balances of the VIE and subsidiaries of the VIE due from/to the Company and the Group’s consolidated subsidiaries.On April 1, 2021, the Group entered into a one-year sublease agreement on its office with a related party and recorded RMB97 in other income for the six month ended June 30, 2021. The lease was early terminated on September 30, 2021.On April 1, 2021, the Group entered into a contract to provide equipment usage service to its related party with a total contact amount of RMB997, of which RMB237 was recorded in other income for the six month ended June 30, 2021. The contract was early terminated on September 30, 2021. 0001792267 2022-01-01 2022-06-30 0001792267 2021-01-01 2021-06-30 0001792267 2022-06-30 0001792267 2021-12-31 0001792267 2021-03-16 0001792267 2021-03-16 2021-03-16 0001792267 2022-06-21 0001792267 2022-06-21 2022-06-21 0001792267 2020-12-31 0001792267 2021-06-30 0001792267 us-gaap:CommonClassAMember 2021-12-31 0001792267 us-gaap:CommonClassBMember 2021-12-31 0001792267 us-gaap:NonrecourseMember 2021-12-31 0001792267 bnr:MachineryAndLaboratoryEquipmentMember 2021-12-31 0001792267 us-gaap:VehiclesMember 2021-12-31 0001792267 bnr:FurnitureAndToolsMember 2021-12-31 0001792267 bnr:ElectronicEquipmentMember 2021-12-31 0001792267 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001792267 us-gaap:ConstructionInProgressMember 2021-12-31 0001792267 bnr:EasumedHoldingLtdMember 2021-12-31 0001792267 bnr:ViesAndSubsidiariesOfViesMember 2021-12-31 0001792267 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-12-31 0001792267 bnr:PrcSubsidiariesMember 2021-12-31 0001792267 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001792267 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001792267 us-gaap:CommonClassAMember 2022-06-30 0001792267 us-gaap:CommonClassBMember 2022-06-30 0001792267 us-gaap:NonrecourseMember 2022-06-30 0001792267 bnr:MachineryAndLaboratoryEquipmentMember 2022-06-30 0001792267 us-gaap:VehiclesMember 2022-06-30 0001792267 bnr:FurnitureAndToolsMember 2022-06-30 0001792267 bnr:ElectronicEquipmentMember 2022-06-30 0001792267 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001792267 us-gaap:ConstructionInProgressMember 2022-06-30 0001792267 bnr:EasumedHoldingLtdMember 2022-06-30 0001792267 bnr:ViesAndSubsidiariesOfViesMember 2022-06-30 0001792267 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-06-30 0001792267 bnr:AfterOneYearMember 2022-06-30 0001792267 bnr:VieAndVieSubsidiariesMember 2022-06-30 0001792267 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001792267 us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001792267 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001792267 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001792267 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001792267 us-gaap:ServiceMember 2022-01-01 2022-06-30 0001792267 us-gaap:ProductMember 2022-01-01 2022-06-30 0001792267 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-06-30 0001792267 bnr:CentralLaboratoryBusinessMember 2022-01-01 2022-06-30 0001792267 bnr:InhospitalBusinessMember 2022-01-01 2022-06-30 0001792267 bnr:PharmaResearchAndDevelopmentServicesMember 2022-01-01 2022-06-30 0001792267 us-gaap:AccountingStandardsUpdate201613Member 2022-01-01 2022-06-30 0001792267 us-gaap:CapitalAdditionsMember us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-06-30 0001792267 bnr:YushengHanMember 2022-01-01 2022-06-30 0001792267 bnr:ShaokunChuaiMember 2022-01-01 2022-06-30 0001792267 bnr:EasumedHoldingLtdMember 2022-01-01 2022-06-30 0001792267 bnr:GuangzhouBurningRockBiologicalEngineeringCoLtdMember 2022-01-01 2022-06-30 0001792267 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001792267 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001792267 country:CN 2022-01-01 2022-06-30 0001792267 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001792267 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001792267 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-06-30 0001792267 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001792267 us-gaap:TreasuryStockMember 2022-01-01 2022-06-30 0001792267 bnr:EquityForwardMember 2022-01-01 2022-06-30 0001792267 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001792267 us-gaap:CommonClassBMember 2022-01-01 2022-06-30 0001792267 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001792267 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0001792267 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001792267 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001792267 us-gaap:ServiceMember 2021-01-01 2021-06-30 0001792267 us-gaap:ProductMember 2021-01-01 2021-06-30 0001792267 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-06-30 0001792267 bnr:CentralLaboratoryBusinessMember 2021-01-01 2021-06-30 0001792267 bnr:InhospitalBusinessMember 2021-01-01 2021-06-30 0001792267 bnr:PharmaResearchAndDevelopmentServicesMember 2021-01-01 2021-06-30 0001792267 us-gaap:AccountingStandardsUpdate201613Member 2021-01-01 2021-06-30 0001792267 bnr:EasumedHoldingLtdMember 2021-01-01 2021-06-30 0001792267 bnr:GuangzhouBurningRockBiologicalEngineeringCoLtd.Member 2021-01-01 2021-06-30 0001792267 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001792267 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001792267 us-gaap:CostOfSalesMember 2021-01-01 2021-06-30 0001792267 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001792267 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-06-30 0001792267 us-gaap:TreasuryStockMember 2021-01-01 2021-06-30 0001792267 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001792267 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001792267 bnr:AccountingStandardsUpdateMember 2021-01-01 2021-01-01 0001792267 bnr:GuangzhouBurningRockBiologicalEngineeringCoLtd.Member 2021-04-01 2021-04-01 0001792267 bnr:GuangzhouBurningRockBiologicalEngineeringCoLtd.Member bnr:OfficeSubleaseAgreementMember 2021-04-01 2021-04-01 0001792267 bnr:ClassACommonSharesInTheFormOfAdsMember bnr:AcceleratedShareRepurchaseProgramMember us-gaap:SubsequentEventMember 2022-08-23 2022-08-23 0001792267 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001792267 us-gaap:RetainedEarningsMember 2021-12-31 0001792267 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001792267 us-gaap:CommonStockMember 2021-12-31 0001792267 us-gaap:CommonStockMember 2022-06-30 0001792267 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001792267 us-gaap:RetainedEarningsMember 2022-06-30 0001792267 bnr:EquityForwardMember 2022-06-30 0001792267 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001792267 us-gaap:TreasuryStockMember 2022-06-30 0001792267 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001792267 us-gaap:RetainedEarningsMember 2020-12-31 0001792267 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001792267 us-gaap:CommonStockMember 2020-12-31 0001792267 us-gaap:CommonStockMember 2021-06-30 0001792267 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001792267 us-gaap:RetainedEarningsMember 2021-06-30 0001792267 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001792267 us-gaap:TreasuryStockMember 2021-06-30 iso4217:USD iso4217:CNY xbrli:shares xbrli:pure utr:Year utr:Month iso4217:USD xbrli:shares iso4217:CNY xbrli:shares
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 
 
FORM
6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2022
Commission File Number:
001-39316
 
 
BURNING ROCK BIOTECH LIMITED
(Registrant’s Name)
 
 
No.5 Xingdao Ring Road North, International Bio Island
Guangzhou, Guangdong
People’s Republic of China
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form
20-F
or Form
40-F.
Form
20-F  ☒                    
Form
40-F  ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(1):  ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101(b)(7):  ☐
 
 
 

EXHIBIT INDEX

This current report on Form 6-K, including Exhibits 99.1 and 99.2 to it, shall be incorporated by reference into the Registrant’s registration statement on Form F-3, which became effective on September 30, 2022 (File no. 333-264577), and be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently furnished.

 

Number

   

Description of Document

99.1    Management’s Discussion and Analysis of Financial Condition and Results of Operations and Recent Developments
99.2    Unaudited Condensed Consolidated Financial Statements

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Burning Rock Biotech Limited
By:  

/s/ Leo Li

Name:   Leo Li
Title:   Chief Financial Officer

Date: November 7, 2022

 

3